ASRT
Assertio Holdings, Inc.
Assertio Holdings, Inc. (ASRT) has 12 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 0 distinct insiders. Most recent filing: May 15, 2026.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Mark L. Reisenauer
- Employees:58
- HQ:Lake Forest, IL, US
- IPO:1997-12-03
No open-market insider trades for ASRT (Assertio Holdings, Inc.) in the last 365 days.
Why this page may be quiet. Tracefour displays Form 4 open-market purchases (P) and sales (S): the two transaction codes that signal directional conviction. Restricted stock grants, option exercises, gifts, and tax-withholding sales are filed but intentionally not shown: they're disclosure mechanics, not buy/sell decisions.
Many large-cap executives trade through pre-scheduled 10b5-1 plans set months in advance and batch-disclosed each quarter, so the latest filing on EDGAR for a mega-cap can be weeks old without any insider actually choosing to trade in that window.
Related companies
Assertio Holdings, Inc. is in the Healthcare sector.